Articles in Scholarly Journals [Incomplete List]

1. Patient, Caregiver and Regimen Characteristics Associated With Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Children and Adolescents
   The Pediatric Infectious Disease Journal, vol. 26, no. 1, pp. 61–67, 2007
2. Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy
   Antiviral Research, vol. 75, no. 2, pp. 159–166, 2007
3. Cognitive Functioning in School-Aged Children With Vertically Acquired HIV Infection Being Treated With Highly Active Antiretroviral Therapy (HAART)
   Developmental Neuropsychology, vol. 30, no. 2, pp. 633–657, 2006
4. Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy: Impact on Bone Mineral Density in HIV-Infected Children
   PEDIATRICS, vol. 118, no. 3, pp. e711–e718, 2006
5. Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy for Pediatric HIV Infection
   PEDIATRICS, vol. 116, no. 6, pp. e846–e854, 2005
6. Human Immunodeficiency Virus Type 1 Vpr-Dependent Cell Cycle Arrest through a Mitogen-Activated Protein Kinase Signal Transduction Pathway
   Journal of Virology, vol. 79, no. 17, pp. 11366–11381, 2005
7. Natural History of Lipid Abnormalities and Fat Redistribution Among Human Immunodeficiency Virus-Infected Children Receiving Long-Term, Protease Inhibitor-Containing, Highly Active Antiretroviral Therapy Regimens
   PEDIATRICS, vol. 114, no. 2, pp. e235–e242, 2004
8. Single-Dose and Steady-State Pharmacokinetics of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Children
   Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 124–129, 2004
9. Host Cell Gene Expression during Human Immunodeficiency Virus Type 1 Latency and Reactivation and Effects of Targeting Genes That Are Differentially Expressed in Viral Latency
   Journal of Virology, vol. 78, no. 17, pp. 9458–9473, 2004
10. Dissection of the Kaposi's Sarcoma-Associated Herpesvirus Gene Expression Program by Using the Viral DNA Replication Inhibitor Cidofovir
    Journal of Virology, vol. 78, no. 24, pp. 13637–13652, 2004
11. Defective Immune Function of Primary Effusion Lymphoma Cells is Associated with Distinct KSHV Gene Expression Profiles
    Leukemia & Lymphoma, vol. 45, no. 6, pp. 1223–1238, 2004
12. Retrovirology, vol. 1, no. 1, p. 42, 2004
13. Global Changes in Kaposi's Sarcoma-Associated Virus Gene Expression Patterns following Expression of a Tetracycline-Inducible Rta Transactivator
    Journal of Virology, vol. 77, no. 7, pp. 4205–4220, 2003
14. Cognitive Decline With Immunologic and Virologic Stability in Four Children With Human Immunodeficiency Virus Disease
    PEDIATRICS, vol. 112, no. 3, pp. 679–684, 2003
15. Long-term Virologic and Immunologic Responses in Human Immunodeficiency Virus Type 1–Infected Children Treated with Indinavir, Zidovudine, and Lamivudine
    The Journal of Infectious Diseases, vol. 183, no. 7, pp. 1116–1120, 2001
16. Transcription Program of Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus)
    Journal of Virology, vol. 75, no. 10, pp. 4843–4853, 2001
17. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-?B activation
    Oncogene, vol. 20, no. 33, Article ID 1204513, 12 pages, 2001
18. Burkitt's/Burkitt's-Like Lymphoma Presenting as Bacterial Sinusitis in Two HIV-Infected Children
    AIDS Patient Care and STDs, vol. 15, no. 9, pp. 453–458, 2001
19. Sino-orbital-cerebral aspergillosis in immunocompromised pediatric patients
    The Pediatric Infectious Disease Journal, vol. 19, no. 12, pp. 1197–1203, 2000
20. Long-Term Telomere Dynamics: Modest Increase of Cell Turnover in HIV-Infected Individuals Followed for up to 14 Years
    Pathobiology, vol. 67, no. 1, pp. 34–38, 1999
21. Human Herpesvirus 8 Cellular Immune Responses in Homosexual Men
    The Journal of Infectious Diseases, vol. 180, no. 5, pp. 1682–1685, 1999
22. The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection
    Virus Research, vol. 53, no. 1, pp. 39–51, 1998
23. A Phase I/II Study of the Protease Inhibitor Indinavir in Children With HIV Infection
    PEDIATRICS, vol. 102, no. 1, pp. 101–109, 1998
24. A Phase I/II Study of the Protease Inhibitor Ritonavir in Children With Human Immunodeficiency Virus Infection
    PEDIATRICS, vol. 101, no. 3, pp. 335–343, 1998
25. Glycocalicin levels in the plasma of HIV+ patients: An indicator of platelet turnover
    Journal of Laboratory and Clinical Medicine, vol. 132, no. 4, pp. 303–307, 1998
26. Umbilical cord blood mononuclear cell HIV-1 LTR binding activities
    Journal of Biomedical Science, vol. 4, no. 5, pp. 217–228, 1997
27. Sodium Butyrate Treatment of Cells Latently Infected with HIV-1 Results in the Expression of Unspliced Viral RNA
    Virology, vol. 196, no. 2, pp. 496–505, 1993